How many insider declarations has Patel Nishitkumar Maheshbhai filed?

Patel Nishitkumar Maheshbhai has filed 2 public insider declarations with SEBI (PIT + SAST).

What is Patel Nishitkumar Maheshbhai's role?

Patel Nishitkumar Maheshbhai's reported role is not specified by the regulator across the filings.

Which companies does Patel Nishitkumar Maheshbhai report trades for?

Patel Nishitkumar Maheshbhai reports trades for Lincoln Pharmaceuticals Limited.

← Executives ★ Sign in to follow

PN

Patel Nishitkumar Maheshbhai

·SEBI (PIT + SAST)

Lincoln Pharmaceuticals Limited

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Discover the complete record of transactions filed by Patel Nishitkumar Maheshbhai. Insider active across 1 company, notably Lincoln Pharmaceuticals Limited. In total, 2 reports have been logged. History available since 26 February 2024. The latest transaction was disclosed on 27 February 2024 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.

Companies and markets linked to Patel Nishitkumar Maheshbhai

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Lincoln Pharmaceuticals Limited (IN)IN insider transactions · SEBI (PIT + SAST)

申报2 总计

●

Patel Nishitkumar Maheshbhai

高管2024年2月27日Lincoln Pharmaceuticals Limited

₹733,5007SEBI ↗

1,000 股@ ₹733.5049.7% 占其流量Equity SharesSEBI:da764219cb9bd4fe3172c42348903d43e666e5f8

●

Patel Nishitkumar Maheshbhai

高管2024年2月26日Lincoln Pharmaceuticals Limited

₹751,1407SEBI ↗

1,000 股@ ₹751.1450.3% 占其流量Equity SharesSEBI:e435230cbd396eebb77476731e4f8535fa2ef364

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PN

Patel Nishitkumar Maheshbhai

·SEBI (PIT + SAST)

Lincoln Pharmaceuticals Limited

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Discover the complete record of transactions filed by Patel Nishitkumar Maheshbhai. Insider active across 1 company, notably Lincoln Pharmaceuticals Limited. In total, 2 reports have been logged. History available since 26 February 2024. The latest transaction was disclosed on 27 February 2024 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.